Neem leaf glycoprotein restores the impaired chemotactic activity of peripheral blood mononuclear cells from head and neck squamous cell carcinoma patients by maintaining CXCR3/CXCL10 balance.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  International Immunopharmacology

• Publication date

  2008-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.intimp.2007.10.015PMID 18182249
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human colorectal cancer.

  2007cited by this paper
• Antibody response against neem leaf preparation recognizes carcinoembryonic antigen.

  2007cited by this paper
• Neem leaf preparation enhances Th1 type immune response and anti-tumor immunity against breast tumor associated antigen.

  2007cited by this paper
• Natural killer cell mediated cytotoxicity of tumor cells initiated by neem leaf preparation is associated with CD40-CD40L-mediated endogenous production of interleukin-12.

  2007cited by this paper
• Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human bladder cancer.

  2007cited by this paper
• Neem (Azadirachta indica) leaf preparation induces prophylactic growth inhibition of murine Ehrlich carcinoma in Swiss and C57BL/6 mice by activation of NK cells and NK-T cells.

  2006cited by this paper
• Regulatory T cells, tumour immunity and immunotherapy

  2006cited by this paper
• Ras-induced modulation of CXCL10 and its receptor splice variant CXCR3-B in MDA-MB-435 and MCF-7 cells: relevance for the development of human breast cancer.

  2006cited by this paper
• Prophylactic Dose of Neem (Azadirachta indica) Leaf Preparation Restricting Murine Tumor Growth is Nontoxic, Hematostimulatory and Immunostimulatory

  2006cited by this paper
• Pretreatment with neem (Azadirachta indica) leaf preparation in swiss mice diminishes leukopenia and enhances the antitumor activity of cyclophosphamide

  2006cited by this paper
• Desensitization of T lymphocyte function by CXCR3 ligands in human hepatocellular carcinoma.

  2005cited by this paper
• Immunostimulatory neem leaf preparation acts as an adjuvant to enhance the efficacy of poorly immunogenic B16 melanoma surface antigen vaccine.

  2005cited by this paper
• Evaluation of interferon-γ, interferon-γ-inducing cytokines, and interferon-γ–inducible chemokines in tuberculous pleural effusions

  2005cited by this paper
• Overexpression of IFN-Induced Protein 10 and Its Receptor CXCR3 in Myasthenia Gravis1

  2005cited by this paper
• Evaluation of interferon-gamma, interferon-gamma-inducing cytokines, and interferon-gamma-inducible chemokines in tuberculous pleural effusions.

  2005cited by this paper
• CXC chemokines in angiogenesis relevant to chronic fibroproliferation.

  2005cited by this paper
• CpG oligodeoxynucleotides stimulate IFN-γ-inducible protein-10 production in human B cells

  2004cited by this paper
• CpG oligodeoxynucleotides stimulate IFN-gamma-inducible protein-10 production in human B cells.

  2004cited by this paper
• CXC chemokines: the regulatory link between inflammation and angiogenesis.

  2004cited by this paper
• The expression of the chemokine receptor CXCR3 and its ligand, CXCL10, in human breast adenocarcinoma cell lines.

  2004cited by this paper
• Neutralization of the chemokine CXCL10 enhances tissue sparing and angiogenesis following spinal cord injury

  2004cited by this paper
• Neem (Azadirachta indica) leaf mediated immune activation causes prophylactic growth inhibition of murine Ehrlich carcinoma and B16 melanoma.

  2004cited by this paper
• The chemokine receptor CXCR3 and its splice variant are expressed in human airway epithelial cells.

  2004cited by this paper
• IFN-γ-Inducible Chemokines Enhance Adaptive Immunity and Colitis

  2003cited by this paper
• IFN-gamma-inducible chemokines enhance adaptive immunity and colitis.

  2003cited by this paper
• IFN‐α2a induces IP‐10/CXCL10 and MIG/CXCL9 production in monocyte‐derived dendritic cells and enhances their capacity to attract and stimulate CD8+ effector T cells

  2002cited by this paper
• Biological activities and medicinal properties of neem (Azadirachta indica)

  2002cited by this paper
• IFN-alpha2a induces IP-10/CXCL10 and MIG/CXCL9 production in monocyte-derived dendritic cells and enhances their capacity to attract and stimulate CD8+ effector T cells.

  2002cited by this paper
• Lymphocyte traffic control by chemokines

  2001cited by this paper
• Proliferative activity of intratumoral CD8(+) T-lymphocytes as a prognostic factor in human renal cell carcinoma: clinicopathologic demonstration of antitumor immunity.

  2001cited by this paper
• Chemokines: extracellular messengers for all occasions?

  1999cited by this paper
• Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration

  1998cited by this paper
• Chemokines and leukocyte traffic

  1998cited by this paper
• Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo.

  1996cited by this paper
• Prognostic significance of pathologic features of hepatocellular carcinoma a multivariate analysis of 278 patients

  1995cited by this paper
• Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm.

  1994cited by this paper
• Alterations in large gut associated lymphatic tissues (LGALT) during experimental colorectal carcinogenesis.

  1993cited by this paper
• Immunomodulatory effects of neem (Azadirachta indica) oil.

  1992cited by this paper
• COLORIMETRIC METHOD FOR DETER-MINATION OF SUGAR AND RELATED SUBSTANCE

  1956cited by this paper

• Spatial Distribution and Prognostic Value of T Cell Subtypes and Immune Biomarkers in p16-Negative HNSCC

  2025cites this paper
• Neem Leaf Glycoprotein disrupts exhausted CD8+ T cell-mediated cancer stem cell aggression.

  2024cites this paper
• Neem leaf glycoprotein binding to Dectin-1 receptors on dendritic cell induces type-1 immunity through CARD9 mediated intracellular signal to NFκB

  2024cites this paper
• The immunomodulatory impact of naturally derived neem leaf glycoprotein on the initiation progression model of 4NQO induced murine oral carcinogenesis: a preclinical study

  2024cites this paper
• Characterization and anti-tumor activities of polysaccharide isolated from Brassica rapa L. via activation of macrophages through TLR2-and TLR4-Dependent pathways.

  2023cites this paper
• Assessment of Anti-Carcinogenic Potential of Neem (Azadirachta indica) Leaf Extract Loaded Calcium Phosphate Nanoparticles against Experimentally Induced Mammary Carcinogenesis in Rats

  2023cites this paper
• Natural Plant Products Mediated Prevention of Cancer Facilitated through Immune Suppression of Treg Cells.

  2023cites this paper
• Azadirachta indica ( neem )-GreenTreasure

  2022cites this paper
• Plasma CXCL3 Levels Are Associated with Tumor Progression and an Unfavorable Colorectal Cancer Prognosis

  2022cites this paper
• Pharmacological Review on Azadirachta indica

  2022cites this paper
• Neem Leaf Glycoprotein mediated epigenetic modification in Oral Squamous Cell Carcinoma

  2022cites this paper
• Role of chemokines in HPV- induced cancers.

  2022cites this paper
• Neem Leaf Glycoprotein in immunoregulation of cancer.

  2022cites this paper
• When Natural Compounds Meet Nanotechnology: Nature-Inspired Nanomedicines for Cancer Immunotherapy

  2022cites this paper
• Exploring the therapeutic potential of Neem (Azadirachta Indica) for the treatment of prostate cancer: a literature review

  2022cites this paper
• Neem leaf glycoprotein salvages T cell functions from Myeloid-derived suppressor cells-suppression by altering IL-10/STAT3 axis in melanoma tumor microenvironment

  2021cites this paper
• Immunomodulators and Phytodrugs

  2021cites this paper
• Analysis of the Prognosis and Therapeutic Value of the CXC Chemokine Family in Head and Neck Squamous Cell Carcinoma

  2021cites this paper
• Natural Compounds Extracted from Medicinal Plants and Their Immunomodulatory Activities

  2020cites this paper
• Neem leaf glycoprotein reverses tumor-induced and age-associated thymic involution to maintain peripheral CD8+ T cell pool.

  2020cites this paper
• Neem Leaf Glycoprotein Facilitates Lung Carcinoma- Associated Antigen-Specific Anti-Cancer Immune Response Utilizing Macrophage-Mediated Antigen Presentation and Induction of Type 1 Cytokines Coupled with Nitric Oxide Production

  2019cites this paper
• Pharmacological activities of neem (Azadirachta indica): A review

  2019cites this paper
• NLGP counterbalances the immunosuppressive effect of tumor-associated mesenchymal stem cells to restore effector T cell functions

  2019cites this paper
• Plant-Derived Immunomodulators

  2019cites this paper
• A 2D mathematical model for tumor angiogenesis: The roles of certain cells in the extra cellular matrix.

  2018cites this paper
• Functional genomics screen with pooled shRNA library and gene expression profiling with extracts of Azadirachta indica identify potential pathways for therapeutic targets in head and neck squamous cell carcinoma

  2018cites this paper
• Tumor promoting role of anti-tumor macrophages in tumor microenvironment.

  2017cites this paper
• Structural and functional characterization of a novel immunomodulatory glycoprotein isolated from ajowan (Trachyspermum ammi L.)

  2017cites this paper
• Chapter 2 The Metastatic Microenvironment

  2017cites this paper
• Progress on Azadirachta indica Based Biopesticides in Replacing Synthetic Toxic Pesticides

  2017cites this paper
• Chapter 7 Neem and Prostate Cancer Therapy

  2016cites this paper
• Neem tree (Azadirachta indica) extract specifically suppresses the growth of tumors in H22-bearing Kunming mice

  2016cites this paper
• Neem leaf glycoprotein optimizes effector and regulatory functions within tumor microenvironment to intervene therapeutically the growth of B16 melanoma in C57BL/6 mice

  2015cites this paper
• Frequency, Suppressive Capacity, Recruitment and Induction Mechanisms of Regulatory T Cells in Sinonasal Squamous Cell Carcinoma and Nasal Inverted Papilloma

  2015cites this paper
• Neem (Azadirachta indica) and its Potential for Safeguarding Health of Animals and Humans: A Review

  2014cites this paper
• Micro/Nano-Engineering of Cells for Delivery of Therapeutics

  2014cites this paper
• Murine carcinoma expressing carcinoembryonic antigen-like protein is restricted by antibody against neem leaf glycoprotein.

  2014cites this paper
• Targeting STAT3 phosphorylation by neem leaf glycoprotein prevents immune evasion exerted by supraglottic laryngeal tumor induced M2 macrophages.

  2014cites this paper
• CHEMICAL INVESTIGATION OF NEEM LEAF GLYCOPROTEIN USED AS IMMUNOPROPHYLACTIC AGENT FOR TUMOR GROWTH RESTRICTION

  2014cites this paper
• A Monoclonal Antibody Against Neem Leaf Glycoprotein Recognizes Carcinoembryonic Antigen (CEA) and Restricts CEA Expressing Tumor Growth

  2014cites this paper
• Neem Leaf Glycoprotein Prophylaxis Transduces Immune Dependent Stop Signal for Tumor Angiogenic Switch within Tumor Microenvironment

  2014cites this paper
• Immunotherapeutic targeting of established sarcoma in Swiss mice by tumor-derived antigen-pulsed NLGP matured dendritic cells is CD8+ T-cell dependent.

  2014cites this paper
• Neem components as potential agents for cancer prevention and treatment.

  2014influential citation
• Serum biomarkers in head and neck squamous cell cancer.

  2014cites this paper
• Neem leaf glycoprotein is nontoxic to physiological functions of Swiss mice and Sprague Dawley rats: histological, biochemical and immunological perspectives.

  2013cites this paper
• Neem Leaf Glycoprotein Activates CD8+ T Cells to Promote Therapeutic Anti-Tumor Immunity Inhibiting the Growth of Mouse Sarcoma

  2013cites this paper
• The Metastatic Microenvironment

  2013cites this paper
• Normalization of Tumor Microenvironment by Neem Leaf Glycoprotein Potentiates Effector T Cell Functions and Therapeutically Intervenes in the Growth of Mouse Sarcoma

  2013cites this paper
• Neem leaf glycoprotein overcomes indoleamine 2,3 dioxygenase mediated tolerance in dendritic cells by attenuating hyperactive regulatory T cells in cervical cancer stage IIIB patients.

  2013cites this paper
• Neem leaf glycoprotein is superior than cisplatin and sunitinib malate in restricting melanoma growth by normalization of tumor microenvironment.

  2013cites this paper
• Neem leaf glycoprotein suppresses regulatory T cell mediated suppression of monocyte/macrophage functions.

  2012cites this paper
• Neem Leaf Glycoprotein Partially Rectifies Suppressed Dendritic Cell Functions and Associated T Cell Efficacy in Patients with Stage IIIB Cervical Cancer

  2011cites this paper
• Neem leaf glycoprotein inhibits CD4+CD25+Foxp3+ Tregs to restrict murine tumor growth.

  2011cites this paper
• Anticancer biology of Azadirachta indica L (neem): A mini review

  2011cites this paper
• Novel Molecular Targets of Azadirachta indica Associated with Inhibition of Tumor Growth in Prostate Cancer

  2011cites this paper
• Neem leaf glycoprotein enhances carcinoembryonic antigen presentation of dendritic cells to T and B cells for induction of anti-tumor immunity by allowing generation of immune effector/memory response.

  2010cites this paper
• Neem leaf glycoprotein matures myeloid derived dendritic cells and optimizes anti-tumor T cell functions.

  2010cites this paper
• Restoration of dysregulated CC chemokine signaling for monocyte/macrophage chemotaxis in head and neck squamous cell carcinoma patients by neem leaf glycoprotein maximizes tumor cell cytotoxicity

  2010cites this paper
• Breast cancer lung metastasis requires expression of chemokine receptor CCR4 and regulatory T cells.

  2009cites this paper
• Evidence of Systemic Th2-Driven Chronic Inflammation in Patients with Metastatic Melanoma

  2009cites this paper
• Induction of type 1 cytokines during neem leaf glycoprotein assisted carcinoembryonic antigen vaccination is associated with nitric oxide production.

  2009cites this paper
• Neem leaf glycoprotein directs T-bet-associated type 1 immune commitment.

  2009cites this paper
• Neem Leaf Glycoprotein Induces Perforin-mediated Tumor Cell Killing by T and NK Cells Through Differential Regulation of IFNγ Signaling

  2009cites this paper
• Neem leaf glycoprotein helps to generate carcinoembryonic antigen specific anti-tumor immune responses utilizing macrophage-mediated antigen presentation.

  2008cites this paper